Integra LifeSciences Holdings Corporation (IART) Financial Statements (2024 and earlier)

Company Profile

Business Address 1100 CAMPUS ROAD
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments457513470199139175
Cash and cash equivalents457513470199139175
Short-term investments      
Receivables263232226275266252
Inventory, net of allowances, customer advances and progress billings325317310316280296
Inventory325317310316280296
Prepaid expense      
Disposal group, including discontinued operation   162   
Other current assets      
Other undisclosed current assets 1179169689099
Total current assets:1,1611,1541,237858775822
Noncurrent Assets
Operating lease, right-of-use asset148858495✕✕
Property, plant and equipment311312288337300269
Intangible assets, net (including goodwill)2,1652,1591,9221,9862,0062,098
Goodwill1,0391,013932954926938
Intangible assets, net (excluding goodwill)1,1271,1469891,0321,0791,160
Deferred income tax assets46577413✕✕
Other noncurrent assets571611152016
Other undisclosed noncurrent assets     76
Total noncurrent assets:2,7282,6292,3782,4452,3332,389
TOTAL ASSETS:3,8903,7823,6153,3033,1083,211
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities182275225269236255
Employee-related liabilities✕✕9376797673
Accounts payable10262551137694
Accrued liabilities8012094778588
Deferred revenue7555✕✕
Debt384534572360
Restructuring reserve  10    
Disposal group, including discontinued operation   12   
Business combination, contingent consideration, liability      23
Deferred revenue and credits✕✕✕✕✕✕11
Contract with customer, liability✕✕✕✕✕4✕
Other undisclosed current liabilities935125   
Total current liabilities:321340401331263349
Noncurrent Liabilities
Long-term debt and lease obligation1,3001,4791,4961,2961,2111,781
Long-term debt, excluding current maturities1,3001,3891,4081,1991,2111,781
Liabilities, other than long-term debt3681732031628954
Deferred revenue97 7✕✕
Contract with customer, liability✕✕✕✕✕9✕
Deferred income tax liabilities63461637✕✕
Other liabilities1391201871188054
Operating lease, liability157908898✕✕
Other undisclosed noncurrent liabilities96106 9717065
Total noncurrent liabilities:1,7641,7581,6991,5551,4701,900
Total liabilities:2,0852,0982,1001,8871,7322,249
Equity
Equity, attributable to parent1,8041,6851,5151,4171,376962
Common stock111111
Treasury stock, value(363)(234)(235)(120)(121)(122)
Additional paid in capital1,2771,2651,2911,2141,193822
Accumulated other comprehensive income (loss)10(45)(74)(76)(45)(24)
Retained earnings879699532399348285
Total equity:1,8041,6851,5151,4171,376962
TOTAL LIABILITIES AND EQUITY:3,8903,7823,6153,3033,1083,211

Income Statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,5581,5421,3721,5181,4721,188
Revenue, net✕✕✕✕✕✕1,188
Cost of revenue
(Cost of Goods and Services Sold)		(587)(598)(521)(565)(571)(449)
Other undisclosed gross profit      14
Gross profit:970945851953901753
Operating expenses(731)(747)(700)(859)(790)(708)
Operating income:2391971519411145
Nonoperating income24261420112
Investment income, nonoperating12791130
Other nonoperating income121941081
Interest and debt expense(50)(50)(72)(54)(65)(35)
Income from continuing operations before equity method investments, income taxes:21317394605711
Other undisclosed income from continuing operations before income taxes 142    
Income from continuing operations before income taxes:21421594605711
Income tax expense (benefit)(33)(46)40(10)353
Income from continuing operations:181169134506165
Income before gain (loss) on sale of properties:✕✕169134506165
Net income available to common stockholders, diluted:181169134506165

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:181169134506165
Other comprehensive income (loss)(12)(5)21(2)(22)40
Comprehensive income:1681641554839104
Other undisclosed comprehensive income (loss), net of tax, attributable to parent6834(19)(29) (6)
Comprehensive income, net of tax, attributable to parent:236198136193998

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: